Its also commonly used to support relaxation and restful sleep, making it an excellent option for those looking to maintain their overall wellness while on a GLP-1
Cross-sectional studies have shown that plasma and tissue glutathione concentrations decrease by approximately 10-15% per decade after age 45, and this decline is accelerated in conditions associated with chronic oxidative stress, including type 2 diabetes, cardiovascular disease, neurodegenerative diseases, HIV/AIDS, chronic liver disease, and chronic obstructive pulmonary disease (COPD) [2][3][10][11]
Commonly reported issues include: Gastrointestinal Distress: Nausea, vomiting, and diarrhea are common, particularly when starting the medication
(Lond.) 42 , 913936 (2022)
[9] Tirzepatide (Mounjaro) is recommended by NICE (TA820) for adults with type 2 diabetes